Search term is required Close Search

Monkeypox: What You Need to Know About Prevention, Identification and Treatment

Exploring the Current Landscape of the Monkeypox Outbreak
Monkeypox Event

December 7, 2022 12:00pm – 1:00pm (CT) Online

CE: 1.0 contact hours of CE including 0.3 hours of pharmacology

In this live webinar, Dr. Sapna Bamrah Morris of the Centers for Disease Control and Prevention (CDC) will discuss the current landscape of the monkeypox outbreak as well as the presentation, screening and treatment of this disease. The webinar offers continuing education (CE) credit for 45 minutes of presentation and 15 minutes of live Q&A.

Event Details
  • Webinar Details

    Monkeypox: What You Need to Know About Prevention, Identification and Treatment


    When:
    December 7, 2022, 12-1 p.m. CT (1–2 p.m. ET).

    Where: Online via the AANP CE Center.

    Cost: Free for AANP members and $25 for non-members.

    CE Credit: This activity is approved for 1.0 contact hours of CE, which includes 0.3 hours of pharmacology, by the American Association of Nurse Practitioners® (AANP). This activity was planned in accordance with AANP Accreditation Standards and Policies.

    Register Now


    About the Webinar

    Nurse practitioners are invited to participate in this free webinar to hear from Dr. Sapna Bamrah Morris, the CDC’s Clinical Escalations Team Lead for the Multinational Monkeypox Outbreak Response, who will share information about the monkeypox outbreak. Hear about the presentation of the disease, screening for monkeypox and treatment options. Presented live, this webinar offers 45 minutes of presentation and 15 minutes of live Q&A with Dr. Bamrah Morris.


    Website Objectives

    1. Define key epidemiologic features of the current U.S. monkeypox outbreak.
    2. Characterize how the clinical presentation of monkeypox during the current U.S. outbreak differs from its classic presentation previously in west and central Africa.
    3. Understand the importance of screening for sexually transmitted infections, including HIV, among those patients who are undergoing evaluation for monkeypox.
    4. Describe current criteria for the use of tecovirimat as a treatment for monkeypox.
  • Speaker

    Webinar Faculty

    Sapna Bamrah Morris, MD, MBA
    Lead, Clinical Escalations Team
    Multinational Monkeypox Outbreak Response